Eculizumab and efgartigimod for the treatment of myasthenia gravis: effectiveness and value : final report
- Collection:
-
Health Policy and Services Research
- Author(s):
-
Tice, Jeffrey A., author
Touchette, Daniel R., author
Nikitin, Dmitriy, author
Campbell, Jon, author
Lien, Pei-Wen, author
Moradi, Ashton, author
Rind, David M., author
Pearson, Steven D., author
Agboola, Foluso, author
- Contributor(s):
-
Institute for Clinical and Economic Review, issuing body.
New England Comparative Effectiveness Public Advisory Council
- Publication:
-
[Boston, Massachusetts] : Institute for Clinical and Economic Review, October 20, 2021
- Language(s):
-
English
- Format:
-
Text
- Subject(s):
-
Immunosuppressive Agents
Myasthenia Gravis -- drug therapy
United States
- Genre(s):
-
Technical Report
- Copyright:
-
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
- Extent:
-
1 online resource (1 PDF file (various pagings))
- Illustrations:
-
Illustrations
- NLM Unique ID:
-
9918400686506676 (See catalog record)
- Permanent Link:
-
http://resource.nlm.nih.gov/9918400686506676
